Absolute neutrophil count >= 1,500/mm^3 [clinicaltrials_resource:3241b394f188f6bbb6582b03f0260008]
eligibility for clinicaltrials:NCT01908101 [clinicaltrials_resource:36f80c7e3fa07fec931d52a1ea698716]eligibility for clinicaltrials:NCT02345460 [clinicaltrials_resource:3b548f1ac3c7857b02c0765565cfe885]eligibility for clinicaltrials:NCT00121290 [clinicaltrials_resource:4ecf3102d87c2eff019e5ad1f9198221]eligibility for clinicaltrials:NCT01038778 [clinicaltrials_resource:6d0f2f530a1eab1aeadd0720c1052a8c]eligibility for clinicaltrials:NCT00054548 [clinicaltrials_resource:a94643c0ce8be09a2abfb811d879cfed]eligibility for clinicaltrials:NCT01463072 [clinicaltrials_resource:a966d1250c0a4e5bfca456724209f7e8]eligibility for clinicaltrials:NCT00126555 [clinicaltrials_resource:c47f4ba70a3c5084fd8aa90eb6087f2d]eligibility for clinicaltrials:NCT00079326 [clinicaltrials_resource:c493813bb2991fe27940ed52569434d2]eligibility for clinicaltrials:NCT00039455 [clinicaltrials_resource:d5e1c2d43bcaee04585e9a1b96e3f2b8]eligibility for clinicaltrials:NCT00787787 [clinicaltrials_resource:e74dbf0f9896cb83922d5fec19848d87]eligibility for clinicaltrials:NCT01434316 [clinicaltrials_resource:f9058acc42314e45194db1201424dc4d]eligibility for clinicaltrials:NCT02159950 [clinicaltrials_resource:f9ba4e612c97a2d3ab9e936c9a1cca44]
exclusion criteria [clinicaltrials_vocabulary:exclusion-criteria]
eligibility for clinicaltrials:NCT00303953 [clinicaltrials_resource:0743f75489dceba8448b81967840087e]eligibility for clinicaltrials:NCT00407654 [clinicaltrials_resource:17f56e548ffbdd7b881dc93aa29a4466]eligibility for clinicaltrials:NCT00087386 [clinicaltrials_resource:1dcdf36881b638564b2dbe9dd1a090ed]eligibility for clinicaltrials:NCT00082784 [clinicaltrials_resource:20c7ef803e81787365b077c6be562548]eligibility for clinicaltrials:NCT00012298 [clinicaltrials_resource:2c72b84984c6a8509f8b98f6ae3e3cc9]eligibility for clinicaltrials:NCT00365053 [clinicaltrials_resource:2f38502774b96230955c533f89d9f5e0]eligibility for clinicaltrials:NCT01908101 [clinicaltrials_resource:36f80c7e3fa07fec931d52a1ea698716]eligibility for clinicaltrials:NCT00459342 [clinicaltrials_resource:3a09addfe93b7eef4a9b040a03997890]eligibility for clinicaltrials:NCT02345460 [clinicaltrials_resource:3b548f1ac3c7857b02c0765565cfe885]eligibility for clinicaltrials:NCT00121290 [clinicaltrials_resource:4ecf3102d87c2eff019e5ad1f9198221]eligibility for clinicaltrials:NCT00085371 [clinicaltrials_resource:5085fe971652de68179f509f20b920a7]eligibility for clinicaltrials:NCT00470301 [clinicaltrials_resource:57cb78babf35b9ceb6ff0167e8a69135]eligibility for clinicaltrials:NCT02031536 [clinicaltrials_resource:5dfe47d15f3a6166b4099676031cf2bd]eligibility for clinicaltrials:NCT00098813 [clinicaltrials_resource:67183f9b57c7f387f1b339300b1960f8]eligibility for clinicaltrials:NCT01642251 [clinicaltrials_resource:696085ff794521bad332cff822f6989b]eligibility for clinicaltrials:NCT01038778 [clinicaltrials_resource:6d0f2f530a1eab1aeadd0720c1052a8c]eligibility for clinicaltrials:NCT00104871 [clinicaltrials_resource:6d5f265f474a382fa2d7a29aae4bb096]eligibility for clinicaltrials:NCT00410904 [clinicaltrials_resource:740cb91f749a254954ae598a778f0c17]eligibility for clinicaltrials:NCT00365391 [clinicaltrials_resource:7f95332a18b838853c0d19d0b61bae5c]eligibility for clinicaltrials:NCT00088933 [clinicaltrials_resource:7fa24947ec120c6dbcaf6a9e733feb07]eligibility for clinicaltrials:NCT01711541 [clinicaltrials_resource:8dec6c8a34133a9868244d052a9c4c15]eligibility for clinicaltrials:NCT01824875 [clinicaltrials_resource:8fc1ee07f56bb40c32c15b2ba2c09bd9]eligibility for clinicaltrials:NCT00095693 [clinicaltrials_resource:9f0b394b4ef021767fbf635343907b47]eligibility for clinicaltrials:NCT00258349 [clinicaltrials_resource:9fdb37d56d63a7460263bce0566f6fe7]eligibility for clinicaltrials:NCT00054548 [clinicaltrials_resource:a94643c0ce8be09a2abfb811d879cfed]eligibility for clinicaltrials:NCT01463072 [clinicaltrials_resource:a966d1250c0a4e5bfca456724209f7e8]eligibility for clinicaltrials:NCT00084461 [clinicaltrials_resource:aabf2d26baa0aec590e96f43f421b227]eligibility for clinicaltrials:NCT00383760 [clinicaltrials_resource:b23d4b0c79d647a6e074cbff18990fe5]eligibility for clinicaltrials:NCT02066181 [clinicaltrials_resource:b75bbb3aebffbab9512c0286dff621a7]eligibility for clinicaltrials:NCT00126555 [clinicaltrials_resource:c47f4ba70a3c5084fd8aa90eb6087f2d]eligibility for clinicaltrials:NCT00079326 [clinicaltrials_resource:c493813bb2991fe27940ed52569434d2]eligibility for clinicaltrials:NCT00039455 [clinicaltrials_resource:d5e1c2d43bcaee04585e9a1b96e3f2b8]eligibility for clinicaltrials:NCT00079131 [clinicaltrials_resource:d6b4d492563e5e7e2b41ef682b4d202b]eligibility for clinicaltrials:NCT01898494 [clinicaltrials_resource:e73e94264e36aadd4f24486bf2764467]eligibility for clinicaltrials:NCT00787787 [clinicaltrials_resource:e74dbf0f9896cb83922d5fec19848d87]eligibility for clinicaltrials:NCT00077298 [clinicaltrials_resource:eb0a2144aca54bbd0ad352e2dae72f22]eligibility for clinicaltrials:NCT01045928 [clinicaltrials_resource:f8a5b7714e7bffafc835cdcae155ce5f]eligibility for clinicaltrials:NCT01434316 [clinicaltrials_resource:f9058acc42314e45194db1201424dc4d]eligibility for clinicaltrials:NCT02159950 [clinicaltrials_resource:f9ba4e612c97a2d3ab9e936c9a1cca44]
inclusion criteria [clinicaltrials_vocabulary:inclusion-criteria]
Absolute neutrophil count >= 1,500/mm^3 [clinicaltrials_resource:3241b394f188f6bbb6582b03f0260008]
Bio2RDF identifier
3241b394f188f6bbb6582b03f0260008
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:3241b394f188f6bbb6582b03f0260008
identifier
clinicaltrials_resource:3241b394f188f6bbb6582b03f0260008
title
Absolute neutrophil count >= 1,500/mm^3
@en
type
label
Absolute neutrophil count >= 1 ...... 1b394f188f6bbb6582b03f0260008]
@en